RENAISSANCE TECHNOLOGIES LLC
Position in RCKT — Rocket Pharmaceuticals, Inc.
CIK 1037389
NEW YORK, NY
Position in RCKT
as of Mar 31, 2026
· filed May 14, 2026
Position Value
$2,281,082
+$802,762 QoQ
Shares Held
637,174
+51.3% QoQ
Ownership
0.584%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
20 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in RCKT Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026RENAISSANCE TECHNOLOGIES LLC holds $3,467,670,450 across 330 Biotechnology names. RCKT ranks #138 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | EXEL |
Exelixis, Inc.
|
13,726,993 | $588,750,729 | |
| 2 | INCY |
Incyte Corp
|
3,651,532 | $343,682,191 | |
| 3 | CORT |
Corcept Therapeutics Inc
|
5,682,783 | $229,072,982 | |
| 4 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
421,688 | $188,300,559 | |
| 5 | JAZZ |
Jazz Pharmaceuticals plc
|
819,374 | $154,902,654 | |
| 6 | GMAB |
Genmab A/S
|
4,414,550 | $118,442,376 | |
| 7 | INVA |
Innoviva, Inc.
|
4,055,632 | $94,496,225 | |
| 8 | ARWR |
Arrowhead Pharmaceuticals, Inc.
|
1,036,495 | $64,988,236 |
All Filings in RCKT
Export CSV
20 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $2,281,082 | 637,174 | Shares | Sole | 2026-05-14 | |
| 2025-12-31 | $1,478,320 | 421,174 | Shares | Sole | 2026-02-12 | |
| 2025-09-30 | $447,197 | 137,177 | Shares | Sole | 2025-11-13 | |
| 2025-06-30 | $1,130,366 | 461,374 | Shares | Sole | 2025-08-13 | |
| 2025-03-31 | $2,257,621 | 338,474 | Shares | Sole | 2025-05-14 | |
| 2024-12-31 | $2,746,783 | 218,519 | Shares | Sole | 2025-02-13 | |
| 2024-06-30 | $2,143,828 | 99,574 | Shares | Sole | 2024-08-09 | |
| 2023-12-31 | $1,878,339 | 62,674 | Shares | Sole | 2024-02-13 | |
| 2023-09-30 | $3,964,282 | 193,474 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $573,726 | 28,874 | Shares | Sole | 2023-08-11 | |
| 2023-03-31 | $1,942,096 | 113,374 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $3,107,716 | 158,800 | Shares | Sole | 2023-02-13 | |
| 2022-09-30 | $7,657,608 | 479,800 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $5,970,464 | 433,900 | Shares | Sole | 2022-08-12 | |
| 2022-03-31 | $2,482,090 | 156,500 | Shares | Sole | 2022-05-13 | |
| 2021-12-31 | $3,313,772 | 151,799 | Shares | Sole | 2022-02-11 | |
| 2021-09-30 | $3,452,085 | 115,493 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $890,229 | 20,100 | Shares | Sole | 2021-08-13 | |
| 2021-03-31 | $2,466,528 | 55,590 | Shares | Sole | 2021-05-13 | |
| 2020-03-31 | $1,305,720 | 93,600 | Shares | Sole | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||